Wednesday, 5 August 2015
Alembic Pharmaceuticals: Expensive valuation restricts upside; downgrade to Neutral says Motilal Oswal Financial Services Ltd http://goo.gl/J3rEXo
Alembic Pharmaceuticals: Expensive valuation restricts upside; downgrade to Neutral says Motilal Oswal Financial Services Ltd http://goo.gl/J3rEXo
http://goo.gl/J3rEXo
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment